Skip to content
Screener

ResMed Inc. RMD Q4 2026 Annual earnings

Reported August 6, 2026 · After market close

Revenue$1.5BBeat by $2.3M
Adjusted EPS$2.95Beat by $0.06
Revenue estimate$1.5B
EPS estimate$2.89
“We closed fiscal year 2026 with strong fourth quarter results, reflecting continued momentum of our global business, sustained demand for our market-leading products, and disciplined execution of our strategy”
Resmed's Chairman

Next report

Oct 29, 2026 (in 2 months)
Revenue estimate$1.4B
EPS estimate$2.69

Financials

Q4 2026

Income statement

See full
Revenue$1.5B+8.6%
Gross profit$861.2M+5.0%
Operating income$448.7M-1.3%
Net income$383.4M+1.0%
EPS (diluted)$2.64+2.3%

Balance sheet

See full
Cash & equivalents$1.5B+21.5%
Total debt$825.9M-4.2%
Total equity$6.6B+10.3%
Total assets$9.0B+9.7%

Cash flow

See full
Operating cash flow$454.6M-15.6%
CapEx$51.1M+67.2%
Free cash flow$403.5M-20.6%

Valuation & ratios

Valuation

as of 08/27/26
See full
Market cap$34B-17.6%
Enterprise value$33.36B-18.5%
P/E22.3×-7.2×
P/S6×-2.0×

Profitability

See full
Gross margin61.1%+1.7pp
Operating margin33.4%+0.6pp
Net margin26.9%-0.3pp
FCF margin29.2%-3.1pp

Returns & leverage

See full
Return on equity24.3%-1.6pp
Debt / equity0.1×0.0×
Current ratio3.1×-0.3×

Segments

By segment

See full
Sleep and Breathing Health$1.3B+9.4%
Residential Care Software$171.9M+2.9%

By product

See full
Sleep and Breathing Health$1.3B+9.4%
Residential Care Software$171.9M+2.9%

FAQ

When did ResMed Inc. report Q4 2026 earnings?
ResMed Inc. (RMD) reported Q4 2026 earnings on August 6, 2026 after market close.
What were ResMed Inc.'s Q4 2026 revenue and EPS?
ResMed Inc. reported revenue of $1.5B and adjusted eps of $2.95 for Q4 2026.
Did ResMed Inc. beat estimates in Q4 2026?
Revenue beat the consensus estimate of $1.5B by $2.3M. EPS beat the consensus estimate of $2.89 by $0.06.
How did ResMed Inc.'s Q4 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 8.6% from $1.3B a year earlier.
Where can I find ResMed Inc.'s Q4 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-337962) and the 10-K periodic report (0000943819-26-000047) directly on SEC EDGAR. The filing index links above go to sec.gov.